宫颈癌新辅助化疗的临床应用现状

被引：17

作者：

李秀琴

张淑兰

机构：

[1] 沈阳中国医科大学附属盛京医院妇产科

来源：

中国妇产科临床杂志 | 2010年 / 11卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R737.33 [子宫肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

引用

收藏

页码：395 / 396

页数：2

相关论文

共 4 条

[1]

Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer [J].

Kim, Kidong ;

Kim, Min-Jeong ;

Chung, Hyun Hoon ;

Choi, Seok-Cheol ;

Ryu, Sang-Young ;

Kim, Jae Weon ;

Park, Noh-Hyun ;

Song, Yong-Sang ;

Kang, Soon-Beom .

MEDICAL HYPOTHESES, 2009, 73 (06) :1005-1007

[2]

The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer [J].

Symonds, RP ;

Habeshaw, T ;

Reed, NS ;

Paul, J ;

Pyper, E ;

Yosef, H ;

Davis, J ;

Hunter, R ;

Davidson, SE ;

Stewart, A ;

Cowie, V ;

Sarkar, T .

EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) :994-1001

[3]

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix [J].

Herod, J ;

Burton, A ;

Buxton, J ;

Tobias, J ;

Luesley, D ;

Jordan, S ;

Dunn, J ;

Poole, CJ .

ANNALS OF ONCOLOGY, 2000, 11 (09) :1175-1181

[4]

Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial [J].

Leborgne, F ;

Leborgne, JH ;

Doldan, R ;

Zubizarreta, E ;

Ortega, B ;

Maisonneuve, J ;

Musetti, E ;

Hekimian, L ;

Mezzera, J .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02) :343-350